The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
Another chronic condition called chronic fatigue syndrome (CFS), or myalgic encephalomyelitis, comprises a complex multisystem disease that is typically characterized by severe fatigue. 2 Both these ...
Fibromyalgia is a common chronic pain condition, affecting the quality of life of affected individuals. It is typically characterized by widespread musculoskeletal pain, but psychiatric disorders, ...
Oral presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant improvement in primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results